3-{[(2,6-dichlorophenyl)sulfonyl]amino}propanoic acid, 95.0%, 500mg

N-(Cyclopropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 1g

4-Fluoro-2-methyl-1-trifluoromethyl-benzene, 98.0%, 250mg

3-(morpholinomethyl)benzophenone, 95.0%, 1g

2-[4-(2-Fluoro-benzyloxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane, 98%, 100mg

5-(Chloromethyl)-3-methyl-1,2,4-oxadiazole, 95.0%, 10g

6-Fluoro-4-nitro-1H-indazole, 95.0%, 250mg

1,3-Diphenyl-1,1,3,3-tetramethyldisilazane, >95.0%, 10g

(R)-1-(2-(Difluoromethoxy)-4-fluorophenyl)ethan-1-amine, 95%, 100mg

3-Bromo-2-(bromomethyl)benzonitrile, 95.0%, 10g

Methyl 4-hydroxypiperidine-4-carboxylate hydrochloride, 95.0%, 500mg

Tricyclo[6.2.1.0(2,7)]undeca-4-ene>96.0%(GC)25mL

5-(2-Fluorophenyl)-1,3,4-oxadiazol-2(3H)-one, 95.0%, 25g